ANGIOSARCOMA
Clinical trials for ANGIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ANGIOSARCOMA trials appear
Sign up with your email to follow new studies for ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancer: drug combo shows promise in advanced angiosarcoma
Disease control CompletedThis study tested two treatments for people with advanced angiosarcoma, a rare cancer of blood vessels, that cannot be removed by surgery. Participants received either a chemotherapy drug called paclitaxel alone or paclitaxel plus another drug called bevacizumab. The goal was to …
Matched conditions: ANGIOSARCOMA
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
Dye-and-glue combo shows promise for blocking dangerous blood vessels
Disease control CompletedThis study looked at the safety of using a special dye (Lipiodol) mixed with surgical glue to block abnormal blood vessels in 132 adults with conditions like hemangiomas or arteriovenous malformations. The procedure aimed to control disease by cutting off blood flow to the proble…
Matched conditions: ANGIOSARCOMA
Phase: PHASE4 • Sponsor: Guerbet • Aim: Disease control
Last updated May 26, 2026 03:55 UTC